CODX vs TMO
Co-Diagnostics, Inc. Common Stock (CODX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CODX currently screens at market cap $31.4M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CODX and TMO stock pages for the full models.
Not investment advice.